Financhill
Back

Halozyme Therapeutics Stock Predictions

Halozyme Therapeutics Stock Forecast

  • Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 30.5% based on the past 21 years of stock performance.
  • Halozyme Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
  • Is Halozyme Therapeutics Stock Undervalued?
    The current Halozyme Therapeutics [HALO] share price is $53.85. The Score for HALO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Halozyme Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 30.5% based on the past 21 years of stock performance.

Halozyme Therapeutics Stock Rating

Buy
66
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics overpriced?

  • Halozyme Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%

Halozyme Therapeutics Stock Price History

Is HALO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com

52-Week Data

52-Week High:
70.51
52-Week Low:
42.01

Prediction Charts

Market Cap:
6.6B
Price in USD:
53.85
Volume:
1.4M
Beta:
1.42

Technical Analysis

SMA50:
57.81
SMA100:
58.44
SMA200:
56.21
52-Wk Change:
7.87%

Stock Predictions

  • Is Halozyme Therapeutics stock public?
    Yes, Halozyme Therapeutics is a publicly traded company.
  • What is the Halozyme Therapeutics stock quote today?
    The Halozyme Therapeutics stock price is 53.85 USD today.
  • How to buy Halozyme Therapeutics stock online?
    You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-22 53.64 53.75 54.19 53.04
May-23 53.23 54.54 54.68 53.03
May-27 55.25 54.42 55.25 53.76
May-28 54.50 54.43 55.09 54.22
May-29 54.69 54.73 54.96 54.00
May-30 54.75 56.07 56.39 54.26
Jun-2 55.69 55.64 56.32 54.49
Jun-3 55.58 53.31 55.58 52.73
Jun-4 53.01 53.85 54.11 53.01
Jun-5 53.66 53.55 54.24 53.21
Jun-6 54.15 54.25 54.76 53.44
Jun-9 54.50 54.38 54.95 54.00
Jun-10 54.28 53.77 54.51 53.54
Jun-11 53.77 53.85 55.60 53.74

Halozyme Therapeutics Earnings

Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Halozyme Therapeutics Forecast Revenue Growth

Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.